Solana Company (HSDT) Q2 2026 Earnings Call Transcript
Solana Company (HSDT) Q2 2026 Earnings Call Transcript
Solana Company (HSDT) Reports Q2 Loss, Lags Revenue Estimates
Solana Company (HSDT) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $79.73 per share a year ago.
Solana Q2 Earnings Call Highlights
Solana NASDAQ: HSDT reported second-quarter 2026 revenue of $2.5 million, driven primarily by staking rewards from its digital asset treasury, as the company continued building its institutional advisory, validator infrastructure and treasury businesses across Asia-Pacific.
Solana Company (HSDT) Q1 2026 Earnings Call Transcript
Solana Company (HSDT) Q1 2026 Earnings Call Transcript
Solana Company (HSDT) Q4 2025 Earnings Call Transcript
Solana Company (HSDT) Q4 2025 Earnings Call Transcript
Solana Company (HSDT) Q3 2025 Earnings Call Transcript
Solana Company ( HSDT ) Q3 2025 Earnings Call November 18, 2025 4:30 PM EST Company Participants Choon Wee Chee - Executive Chairman Cosmo Jiang Dane Andreeff - President, CEO & Director Jeff Mathiesen - CFO, Treasurer & Secretary Presentation Operator Hello, and thank you for standing by. Welcome to Solana Company's Third Quarter Operating Results Conference Call.
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference
NEWTOWN, Pa., Oct. 18, 2024 – PRISM MediaWire – Helius Medical Technologies, Inc.
Helius Medical Technologies, Inc. (HSDT) Q2 2024 Earnings Call Transcript
Helius Medical Technologies, Inc. (NASDAQ:HSDT ) Q2 2024 Results Conference Call August 12, 2024 4:30 PM ET Company Participants Michelle Bilski - IR Dane Andreeff - President and CO Jeff Mathiesen - CFO Conference Call Participants Anthony Vendetti - Maxim Group Operator Good day, and thank you for standing by. Welcome to the Helius Medical Technologies Second Quarter 2024 Earnings Conference Call [Operator Instructions].
Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference
NEWTOWN, PA / ACCESSWIRE / May 31, 2024 / Helius Medical Technologies, Inc., (Nasdaq:HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that it will participate in the Spring MicroCap Rodeo Conference to be held on Thursday, June 6th in NYC. Dane Andreeff, CEO, will attend the conference and plans to discuss: Pursuit of a stroke authorization in the U.S. for its Portable Neuromodulation Stimulator (PoNS®) device with the U.S. Food and Drug Administration (FDA); Helius' partnership with Lovell® Government Services to make PoNS available to federal healthcare systems, including the U.S. Department of Veterans Affairs (VA) and Department of Defense (DoD).
